Literature DB >> 12746945

Determination of maximal voluntary ventilation in children with cystic fibrosis.

Richard Stein1, Hiran Selvadurai, Allan Coates, Donna L Wilkes, Jane Schneiderman-Walker, Mary Corey.   

Abstract

Maximal voluntary ventilation (MVV) may be determined directly by the sprint method or calculated from pulmonary function data, using the functions MVV = forced expired volume in 1 sec (FEV(1)) x 35 or MVV = FEV(1) x 40. The purpose of this paper was to test the validity of the equation over a wide range of lung function in children. Cystic fibrosis (CF), a chronic lung disease where children typically have a wide range of pulmonary function, was chosen as the study requirement. Spirometric data from 332 children with CF who underwent pulmonary function testing between 1987-2000 were stratified according to disease severity, and box-plots comparing the ratio of MVV to FEV(1) for each category were generated. As results indicated that the equation underestimates true MVV proportionally to the degree of airflow limitation, a new function to predict MVV for this population was derived and tested. The new equation was derived using data from patients who were tested on odd-numbered days (group A). The validity of the new equation was then tested on the patients tested on even-numbered days (group B). To test its validity, the results were compared to the "gold standard" sprint values using a Bland and Altman plot. MVV was expressed as a function of FEV(1) and predicted FEV(1): MVV = 27.7(FEV(1)) + 8.8(PredFEV(1)) (R(2) = 0.98, P < 0.05). In this way, the accuracy of the new equation was confirmed. Whenever possible, we recommend MVV be determined by the sprint method in accordance with ATS guidelines. If this is not feasible, we recommend considering the new prediction equation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12746945     DOI: 10.1002/ppul.10298

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  10 in total

1.  Exercise testing in cystic fibrosis: why (and how)?

Authors:  D S Urquhart
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

2.  Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis.

Authors:  Daniel Stevens; Patrick J Oades; Craig A Williams
Journal:  Eur J Pediatr       Date:  2014-08-14       Impact factor: 3.183

3.  Clinical and genetic correlates of exercise performance in young children with cystic fibrosis.

Authors:  Michael G McBride; Joan I Schall; Babette S Zemel; Virginia A Stallings; Richard F Ittenbach; Stephen M Paridon
Journal:  Percept Mot Skills       Date:  2010-06

4.  Exercise testing in patients with cystic fibrosis-importance of ventilatory parameters.

Authors:  Matthew A Tucker; Nichole Lee; Paula Rodriguez-Miguelez; Jacob Looney; Reva H Crandall; Caralee Forseen; Kathleen T McKie; Ryan A Harris
Journal:  Eur J Appl Physiol       Date:  2018-10-24       Impact factor: 3.078

5.  Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.

Authors:  Paul Harmatz; Zi-Fan Yu; Roberto Giugliani; Ida Vanessa D Schwartz; Nathalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; J Edmond Wraith; Michael Beck; Laila Arash; Maurizio Scarpa; David Ketteridge; John J Hopwood; Barbara Plecko; Robert Steiner; Chester B Whitley; Paige Kaplan; Stuart J Swiedler; Karen Hardy; Kenneth I Berger; Celeste Decker
Journal:  J Inherit Metab Dis       Date:  2010-02-06       Impact factor: 4.982

6.  Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.

Authors:  Barbara K Smith; Shelley W Collins; Thomas J Conlon; Cathryn S Mah; Lee Ann Lawson; Anatole D Martin; David D Fuller; Brian D Cleaver; Nathalie Clément; Dawn Phillips; Saleem Islam; Nicole Dobjia; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

7.  Effect of altering breathing frequency on maximum voluntary ventilation in healthy adults.

Authors:  Eric V Neufeld; Brett A Dolezal; William Speier; Christopher B Cooper
Journal:  BMC Pulm Med       Date:  2018-05-24       Impact factor: 3.317

8.  The effect of test modality on dynamic exercise biomarkers in children, adolescents, and young adults.

Authors:  Ronen Bar-Yoseph; Janos Porszasz; Shlomit Radom-Aizik; Annamarie Stehli; Pearl Law; Dan M Cooper
Journal:  Physiol Rep       Date:  2019-07

9.  Maximal Voluntary Ventilation Should Not Be Estimated From the Forced Expiratory Volume in the First Second in Healthy People and COPD Patients.

Authors:  Matías Otto-Yáñez; Antônio José Sarmento da Nóbrega; Rodrigo Torres-Castro; Palomma Russelly Saldanha Araújo; Catharinne Angélica Carvalho de Farias; Armele de Fátima Dornelas De Andrade; Homero Puppo; Vanessa Regiane Resqueti; Guilherme Augusto de Freitas Fregonezi
Journal:  Front Physiol       Date:  2020-06-09       Impact factor: 4.566

10.  Adaptation to reduced lung function in children and young people with spinal deformity.

Authors:  Fiona Jagger; Athanasios I Tsirikos; Sarah Blacklock; Don S Urquhart
Journal:  J Clin Orthop Trauma       Date:  2020-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.